STON1-GTF2A1L
Basic information
Region (hg38): 2:48529925-48776517
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STON1-GTF2A1L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 34 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 36 | 1 | 1 |
Variants in STON1-GTF2A1L
This is a list of pathogenic ClinVar variants found in the STON1-GTF2A1L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-48580809-G-A | not specified | Uncertain significance (May 11, 2022) | ||
2-48580986-G-T | Benign (Dec 13, 2017) | |||
2-48582194-T-C | not specified | Uncertain significance (Feb 14, 2024) | ||
2-48591794-G-T | Myoepithelial tumor | Uncertain significance (Nov 01, 2022) | ||
2-48595258-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
2-48617882-G-C | not specified | Uncertain significance (May 04, 2022) | ||
2-48620875-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
2-48620897-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
2-48621216-G-A | not specified | Uncertain significance (Apr 08, 2022) | ||
2-48621265-G-C | not specified | Uncertain significance (Sep 06, 2022) | ||
2-48646457-C-G | not specified | Uncertain significance (Oct 29, 2021) | ||
2-48646471-A-G | not specified | Uncertain significance (Aug 02, 2022) | ||
2-48646471-A-T | not specified | Uncertain significance (Dec 23, 2022) | ||
2-48646512-A-G | not specified | Uncertain significance (Dec 08, 2023) | ||
2-48646525-C-T | not specified | Uncertain significance (Jul 19, 2022) | ||
2-48646611-A-G | not specified | Uncertain significance (Sep 15, 2021) | ||
2-48646648-A-G | not specified | Uncertain significance (Sep 17, 2021) | ||
2-48646651-A-C | not specified | Uncertain significance (Jan 19, 2024) | ||
2-48646656-G-A | not specified | Likely benign (Dec 07, 2021) | ||
2-48646657-C-T | not specified | Uncertain significance (May 25, 2022) | ||
2-48646675-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
2-48646717-T-C | not specified | Uncertain significance (Sep 14, 2022) | ||
2-48646723-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
2-48646731-A-G | not specified | Uncertain significance (May 16, 2023) | ||
2-48646734-G-A | not specified | Uncertain significance (May 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STON1-GTF2A1L | protein_coding | protein_coding | ENST00000394754 | 10 | 246591 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.52e-22 | 0.0180 | 124654 | 0 | 228 | 124882 | 0.000913 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.79 | 779 | 589 | 1.32 | 0.0000282 | 7732 |
Missense in Polyphen | 298 | 241.07 | 1.2361 | 3293 | ||
Synonymous | -2.44 | 262 | 216 | 1.21 | 0.0000109 | 2255 |
Loss of Function | 1.03 | 38 | 45.5 | 0.835 | 0.00000225 | 594 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00211 | 0.00211 |
Ashkenazi Jewish | 0.00202 | 0.00179 |
East Asian | 0.00234 | 0.00234 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000818 | 0.000803 |
Middle Eastern | 0.00234 | 0.00234 |
South Asian | 0.000770 | 0.000752 |
Other | 0.00117 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in the endocytic machinery. {ECO:0000250}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 1.24
- rvis_percentile_EVS
- 93.31
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.139
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.106
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;endocytosis;regulation of endocytosis
- Cellular component
- transcription factor TFIIA complex;membrane
- Molecular function